Diabetes trials

Diabetes Victoria provides this information as a service to the community and it is the responsibility of the individual to determine the appropriateness of participating in a study.

Diabetes Victoria does not take any responsibility whatsoever arising out of individuals participating in a study and recommend them to seek their own advice from their ususal medical practitioner or any other appropriate source deemed necessary before consenting to participate.


Information about clinical trials

Diabetes clinical trials are an essential part of the development of new interventions and tests that may help to improve your diabetes or improve the health care of others.

As a consumer you might be interested to know information about:

  • What is a clinical trial?
  • Why be part of a clinical trial?
  • How to be part of a clinical trial?
  • How to find a clinical trial?

The Australian Clinical Trials website contains general information that addresses all of these questions about clinical trials in Australia.

top


Current diabetes trials

Carers / Parents

General

Diabetes prevention
No current trials

Gestational Diabetes
No current trials

Health Professionals
No current trials

Pregnancy

Type 1 diabetes

Type 2 diabetes

top


Useful links

Clinical Trials Connect : Clinical Trials Connect Pty Ltd (CTC) is an online patient recruitment service designed to help people interested in volunteering for medical research find clinical trials that are relevant to them.

Australian Clinical Trials:: This website aims to provide reliable and up-to-date information and advice about clinical trials in Australia. It provides easy to understand information about clinical trials in Australia and how to become involved in a clinical trial.

Australian New Zealand Clinical Trials Registry: : The Australian New Zealand Clinical Trials Registry (ANZCTR) is an online register of clinical trials being undertaken in Australia, New Zealand and elsewhere.

Australian Type 1 Diabetes Clinical Research Network
The T1DCRN is a network of clinicians, researchers and people connected to type 1 diabetes who are dedicated to accelerating clinical research progress to increase access to new treatment and therapies for all people living with type 1 diabetes.

top

Do you look after someone at home? Call for volunteers aged 55+ to participate in research at home

The National Ageing Research Institute (NARI), together with Carers Victoria and the University of Melbourne are undertaking a project to investigate the effectiveness of a physical activity program on depression among people who are carers (that is, people who care for someone at home).

You can help us with the IMPACCT study if you:

  • are 55 years of age or over
  • are caring for & living with someone who is aged 60 years or over,
  • have recently experienced a lower mood than usual or symptoms of depression
  • live within Metropolitan Melbourne, Ballarat or Geelong Regions


To find out more information about this project, please download the information flyer and contact Edwina McCarthy on 03 8387 2315 or email This email address is being protected from spambots. You need JavaScript enabled to view it.

top

The effect of work and family conflict on quality of life of parents and children

Parents – does your child have a chronic health condition such as type 1 diabetes?

Researchers from The University of Queensland are seeking parent volunteers to participate in a study into how work and family conflicts affect your quality of life and that of your child.

To participate, all you need to do is complete an online questionnaire. Your input may help determine the effectiveness of parenting interventions on quality of life.

Download the parent and children information sheet.

Complete the online questionnaire

For further information, contact Principal Investigator Antonia Kish on 07 3365 7171 or via This email address is being protected from spambots. You need JavaScript enabled to view it..

This research trial has been approved by The University of Queensland Behavioural and Social Sciences Ethical Review Committee – Approval number 2015000052.

top


Qualitative study of the transition from type 1 diabetes paediatric care to adult care: Perspectives of parents, young people health professionals   

Are you:

  • A young person (aged 16-20) living with type 1 diabetes? OR a parent/guardian of a child (aged 16-20) living with type 1 diabetes?
  • Interested in helping shape information about moving from child to adult diabetes services?

NDSS is developing resources to make the transition process easier for young people with type 1 diabetes. We would love to interview you to hear your views and suggestions.

What could make / could have made things easier for you? What topics would you like to find out more about?  Share your thoughts and opinions with us and help shape information for all young people with type 1 diabetes.

You will receive a pair of movie tickets for your trouble! We will only require 30-45 minutes of your time via telephone.
If you are interested, please contact Virginia (e: This email address is being protected from spambots. You need JavaScript enabled to view it. or telephone: 03 9667 1715) and we will organise a time that suits you.

This study has been approved by the Deakin University Human Research Ethics Committee.

 

top


Your experiences and opinions on diabetes education and services

  • Are you 18-35 years old?
  • Living with type 1 or 2 diabetes?
  • Currently living in Australia?

 If so, Deakin University wants to hear from you!

This research study wants to find out about your experiences and opinions on diabetes education and services.
Interested participants will be required to:

  • take part in an interview or focus group online via Skype or Facetime or in person at Deakin University, Burwood and
  • fill out an online questionnaire.

For more information please contact Ashley Ng at This email address is being protected from spambots. You need JavaScript enabled to view it.
This research study has been given ethics approval by Deakin University Human Ethics Advisory Group.

top


Optimal Health Program for people with diabetes

The Optimal Health Program is a self-management program which aims to support people improve health by building on strengths and values and offering practical strategies to support well-being.

The Optimal Health Program helps individuals to:

  • recognise their strengths.
  • learn ways to understand the links between diabetes and mood including differences between anxiety and hypoglycaemia and strategies for coping with diabetes related distress and burn out.

The Optimal Health Program includes:

  • 8 one-to-one, hour-long sessions with a trained program facilitator
  • program manual
  • refresher session 3 months after completing the 8-week program

This is a randomised control trial meaning half of participants will participate in the program group and half will be in the control group (with the program available after a year).

If you are interested in this program and would like to find out further information, download the information brochure or contact Casey O’Brien 03 9231 3426 or via email This email address is being protected from spambots. You need JavaScript enabled to view it.
This research trial has been approved by St Vincent’s Hospital Human Research Ethics Committee HREC-A 036/14

top

Writing for health

The University of New South Wales and St Vincent’s Hospital, Sydney, have developed “Writing for Health” - a new online program for people with diabetes.  It includes three simple online writing exercises, which aim to improve adjustment to living with diabetes and mental and physical health.

We are looking for volunteers to take part in a trial of this new program and would greatly value your feedback. Participation is free and can be done from your own home.

You may be eligible to take part if you:

  • Have type 1 or type 2 diabetes
  • Are aged 18 years or over
  • Are able to read, write and speak English
  • Are not currently experiencing a significant mental illness

For more information, please visit the Writing for Health website:  https://writingforhealth.ehat.com.au

This study has been approved by the St Vincent’s Hospital HREC (Reference Number HREC 13/SVH 379).

top

Heart attack…stroke…. are you at risk?

Heart attacks can happen at any time to anyone.  It is important to know if you are at risk.  There are many factors that increase your chances of having a heart attack including:

  • Previous heart attack
  • Heart related disease
  • High cholesterol
  • High blood pressure
  • Diabetes

Local physicians are conducting a research study of an investigational medication and its ability to reduce your risk of having a heart attack and other cardiovascular events such as a stroke.  If you are currently taking a medication to lower your cholesterol and have one or more of the conditions listed above, you may qualify for participation in this study.  All testing, treatment and parking will be provided free of charge.

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or This email address is being protected from spambots. You need JavaScript enabled to view it.

This project has been approved by the Austin Health and St Vincent’s Hospital (Melbourne) Human Research Ethics Committee: HREC 12/SVHM/2.

top


Weight Loss Maintenance Study

People aged 18-65 years are invited to participate in an online study investigating why weight loss maintenance is so difficult & what can be done to improve successful weight loss. Participants will go into the draw to win one of two $100 gift vouchers. The study is being conducted by Ms. Jessica Newhouse, Candidate, Doctor of Psychology (Health). For further information please visit the Facebook page, or contact Jessica; This email address is being protected from spambots. You need JavaScript enabled to view it..">This email address is being protected from spambots. You need JavaScript enabled to view it.. To participate in the study please click here.

Ethics approval for this study has been granted by the Human Research Ethics Unit of Deakin University.

top


Kidney health during pregnancy

  • Do you have diabetes – either type 1 or 2?
  • Are you female < 40 years old?
  • Are you planning a pregnancy or within the first 12 weeks of pregnancy?

If you meet the above criteria then you might be interested in this study.  During pregnancy, the woman’s body undergoes remarkable changes, including the kidneys.  This study involves blood tests and ultrasounds of the kidneys (NO radiation), before (if possible), during and after your pregnancy.  To find out more about the study, please download the information flyer and letter of invitation to participate in research.

Please contact Jas-mine Seah on 03 9496 2288, 0412 931 059 or This email address is being protected from spambots. You need JavaScript enabled to view it.  for further information.

top


An exploration of factors associated with eating behaviour in individuals with type 1 diabetes

  • Would you like to participate in research?
  • Are you aged between 18 and 40 years?
  • Do you have type 1 diabetes?

If you answered yes to these questions, please consider participating in this study.  The research team from the Queensland University of Technology is looking for participants to complete a 30-45 minute online survey. To recognise your contribution should you choose to participate, we are offering you the chance to win one of five $50 Coles/Myer vouchers.

Please click on the following link for more detailed information about this study and/or to access the online survey.       

This research trial has been approved by the Queensland University of Technology Research Ethics Unit.

top


ENDIA Study – Finding the causes of Type 1 Diabetes in Early Childhood

If you are planning or expecting a baby, or have a baby less than 6 months old, and

  • The baby’s mother or father has Type 1 Diabetes, or
  • You have another child with Type 1 Diabetes

Then your family may be eligible to participate in the ENDIA Study

The ENDIA (Environmental Determinants of Islet Autoimmunity) study is finding out what causes Type 1 Diabetes so we can find ways to prevent it. We already know that a child’s genes can increase their risk of developing Type 1 Diabetes. However, Type 1 Diabetes in children is twice as common in Australia as it was 20 years ago. This is because our environment has changed. If we can understand exactly what in the environment is harmful or protective, we can modify the environment to try and prevent Type 1 Diabetes.

This research trial has been reviewed and approved by the Human Research Ethics Committees (HRECs) representing the various sites that are participating in ENDIA.

For more information vist the ENDIA website, download the flyer or This email address is being protected from spambots. You need JavaScript enabled to view it.

top


GleeT1D trial for people recently diagnosed with type 1 diabetes

 GleeT1D will determine if a drug called Imatinib can restore pancreatic function in people with newly-diagnosed type 1 diabetes.

The study is being run in the US and in Melbourne, and will involve 66 participants. Imatinib has been used for a decade to treat chronic myeloid leukaemia. The observation that it dramatically reduced the need for insulin in people who also had diabetes lead researchers to plan this study.

More information can be obtained at www.gleevect1d.com or by phoning the Royal Melbourne Hospital Diabetes Research team on 03 93427063.

This research has been approved by Melbourne Health Human Research Ethics Committee HREC/14/MH/303.

top


FIDO: Feeling In charge of diabetes online

  • Are you aged 16 to 25?
  • Do you have type 1 diabetes?
  • Are you looking for a free, private, 24/7 online tool for support?
  • Would you like to go into a draw for an iPad?Y

You are invited to take part in research to help the Black Dog Institute find the right way to offer support to young people like you. They are looking at a program that can be accessed online 24/7 on your computer, tablet, or smartphone.For more information: Please visit https://fido.ehat.com.au or contact Veronica Vatiliotis on (02) 9382 9275 or email at This email address is being protected from spambots. You need JavaScript enabled to view it.  or download the flyer.

This study has been approved by St Vincent’s Hospital HREC reference number: HREC/14/SVH/31.

top


TrialNet studies to prevent other family members getting type 1 diabetes

Type 1 Diabetes TrialNet is a network of 18 clinical centres dedicated to conducting diabetes prevention research and studying intervention therapies for children and adults with newly diagnosed diabetes.

TrialNet in Australia is screening relatives of people with type 1 diabetes to find out if these family members are at risk for developing diabetes. Screening involves a simple blood test for the presence of diabetes-related autoantibodies that may appear years before type 1 diabetes develops.

You may be screened to determine your risk of diabetes if;

  • are between 1 and 45 years of age and have a first degree blood relative (brother, sister, child, parent) with type 1 diabetes, OR
  • you are between 1 and 20 years of age and have a second degree blood relative (grandparent, half-brother, or half-sister with type 1 diabetes) with type 1 diabetes.

Relatives of people with type 1 diabetes have about a 5 percent chance of testing positive for autoantibodies associated with diabetes.

There is no cost for the test.

How Will You Benefit From Screening and Further Risk Assessment?

If you learn you are at risk for developing type 1 diabetes, additional tests will be offered to estimate your chances of developing type 1 diabetes. If you qualify, you may have an opportunity to be enrolled in either the Natural History or a prevention study. All research volunteers will be closely monitored for early detection of type 1 diabetes.

You will be part of a research program that may help other people at risk for type 1 diabetes.

For further information about this research visit the TrialNet website or contact Felicity Healy via This email address is being protected from spambots. You need JavaScript enabled to view it. or phone 03 9342 7063

top


Do you have type 2 diabetes and are you concerned about your weight?

If you have answered yes, researchers at Austin Health are seeking volunteers with type 2 diabetes who are interested in participating in a placebo-controlled weight loss research study of an investigational medication.

You may qualify for the trial if:

  • You are obese (Body Mass Index between 30-60 kg/m2)
  • You have type 2 diabetes
  • You are between 18-65 years of age
  • You must be willing to participate in a 52 week research study involving approximately 12 outpatient visits.


For more information or to see if this trial is suitable for you, please contact Research Coordinator, Austin Health, Nicky 03 9496 2645 or email: This email address is being protected from spambots. You need JavaScript enabled to view it.

This research study has been approved by the Austin Health Human Research Ethics Committee (HREC ZAF-203)

top


Stand Up & Go study

Would you like to become more physically active, and reduce your sitting time to support your brain health?

The National Ageing Research Institute (NARI) is looking for volunteers to join the Stand Up & Go study, a sitting time reduction and physical activity program which is about improving physical and brain health through exercise.

Researchers are looking for people who are:

  • Aged between 50 and 85
  • Have type 2 diabetes
  • Do less than 1 hour of exercise per week

Participants may have the opportunity to engage in a 12 week home-based physical activity program (walking), and will partake in education workshops, and have two assessments (memory, fitness, brain imaging and blood tests) during the study.

If you or someone you know may be interested in participating or would like further information, please contact: Jenny Southam on 03 8387 2377 or by email This email address is being protected from spambots. You need JavaScript enabled to view it.

This study has been approved by the Melbourne Health Research Ethics Committee (HREC 2013.316).

top


THE CREDENCETM Study

Do you have type 2 diabetes? Do you have problems with your kidneys?

If the answer to both questions is Yes, you may be able to take part in a clinical research study.

The CREDENCETM Study is looking at an investigational (study) medication (taken as a daily capsule) that may help protect the kidneys in people with type 2 diabetes.
They are looking for people who:

  • Are 30 years of age or older
  • Have a diagnosis of type 2 diabetes
  • Have kidney problems related to their diabetes
  • Are currently taking medicines to control their kidney problems?

If you choose to take part in the CREDENCETM Study, you will be looked after by an experienced study team who will carefully monitor your health and support your diabetes management.  You will continue to take your current diabetes medications.

For more information please contact: Nicky Robinson on 9496 2645 or This email address is being protected from spambots. You need JavaScript enabled to view it.

This study has been approved by the Austin Health Human Research Ethics Committee. HREC: 28431754DNE3001

top


Attitudes toward depression and treatment options among Australians with a chronic illness

Do you have type 2 diabetes?

RMIT University is currently recruiting participants for research investigating attitudes towards depression in Australians who have a chronic illness.

This study will be looking at the relationship between beliefs about the cause of depression, attitudes toward depression, and the influence this has on seeking and adhering to treatment for depression.

If you wish to participate, it will take around 15 minutes of your time to complete a short survey!

Take the  online survey

This research survey has been given ethics approval by RMIT Human Research Ethics Committee.

top


Do you have type 2 diabetes?

The research team at the Metabolic Disorders Centre, Heidelberg Repatriation Hospital are testing the effect of an investigational drug on cardiovascular events (heart attack and stroke) in patients with type 2 diabetes who may be at risk of these events.

If you are male or female aged 50 years or older have type 2 diabetes and have never had a heart attack or stroke, you may qualify for a clinical trial.

You will be medically supervised. There will be no costs involved. Visits are at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital.

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or This email address is being protected from spambots. You need JavaScript enabled to view it..

This project has been approved by the Austin Health and St Vincent’s Hospital (Melbourne) Human Research Ethics Committee D: HREC D513BC00001.

top


Obesity Study

The Metabolic Disorders Centre, Heidelberg Repatriation Hospital are currently studying the effects of a clinical trial medication in overweight patients with a history of heart disease, type 2 diabetes and multiple cardiac risk factors.

They are currently looking for volunteers with one or more of the conditions listed below:

  • Previous heart attack
  • Angioplasty or heart bypass surgery
  • Previous stroke or carotid surgery
  • A blocked artery in the leg which causes symptoms (pain, reduced walking)
  • Previous vascular surgery or amputation of lower limbs
  • Diabetes with high cholesterol and /or high blood and/or reduced kidney function

This is a large investigational study involving approximately 12,000 patients worldwide. Trial visits are held at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital.  All testing, treatment and parking will be provided free of charge.  

If interested, please contact Nicky Robinson from the Metabolic Disorders Centre, Heidelberg Repatriation Hospital on 03 9496 2645 or This email address is being protected from spambots. You need JavaScript enabled to view it.

This project has been approved by the Austin Health and St Vincent’s Hospital (Melbourne) Human Research Ethics Committee D: HREC APD356-G000401.

top


Health Benefits of Exercise, Protein and Vitamin D for Type 2 Diabetes

Come and join a new study conducted by Deakin University in Burwood to investigate the health benefits of vitamin D and protein combined with resistance training versus resistance exercise alone, in the management of type 2 diabetes.

You can take part in this trial if you;

  • Have type 2 diabetes
  • Are aged 50 years or over

From your involvement in this study you will receive;

  • free assessment of your muscle strength and function
  • free bone density and body composition assessments
  • free blood lipid and cholesterol measures
  • free assessment of your vitamin D levels

For further information, please contact Eliza Miller on 03 9244 6739 or This email address is being protected from spambots. You need JavaScript enabled to view it. or Belinda DeRoss on 03 9246 8286 or This email address is being protected from spambots. You need JavaScript enabled to view it..

top


Seeking overweight or obese individuals with type 2 diabetes

Baker IDI Heart & Diabetes Institute is conducting a study to examine how weight loss influences stress hormones and the nervous system.

To be eligible you need to be:

  • Male or female with type 2 diabetes
  • Not on drug treatments (diet managed)
  • Aged 45 to 65 years
  • A non-smoker
  • Body mass index (BMI) > 27 kg/m2
  • Post-menopausal (women)

The study has been approved by the Alfred Hospital Ethics Committee

For further information about the study download the information flyer, or contact Dr Nora Straznicky on (03) 8532 1371 or This email address is being protected from spambots. You need JavaScript enabled to view it.

top

Do you have type 2 diabetes and elevated urinary protein?

Baker IDI Heart and Diabetes Institute is currently examining whether a new treatment, called moxonidine, helps to lower urinary protein excretion, a major risk factor for kidney and cardiovascular complications.

To be eligible to participate you must be aged between 18 and 75 years, have type 2 diabetes and have elevated levels of protein in your urine.

For further information about the trial contact Robyn Larsen on 03 8532 1859 or This email address is being protected from spambots. You need JavaScript enabled to view it.

top